ARNOLD & PORTER KAYE SCHOLER LLP

Lobbying for REGENERON PHARMACEUTICALS, INC. · Biopharmaceutical development and manufacturing

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · New York · House · Senate · $50,000.00 income · posted Jul 20, 2026

Lobbying activity 1

Health Issues

Outreach related to drug pricing policies

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem